NCT00021424View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2001

Conditions
Head and Neck CancerMetastatic Cancer
Interventions
BIOLOGICAL

recombinant fowlpox-TRICOM vaccine

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

NCT00021424 - Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer | Biotech Hunter | Biotech Hunter